Skip to content
  • About us
    • Management
    • Board of directors
  • PATIENT CARE
    • IOR
    • IBCC
    • IOB
  • PANGAEA LAB
    • Our Services
      • Molecular diagnostics
      • DX Platforms validation
      • Pre-clinical services
    • R + D
    • Accreditations
  • Publications & newsroom
  • Investors
    • Investor information
    • Corporate governance
    • Financial information
    • Events & Corporate Presentations
    • Inside & other relevant information
  • Contact
  • About us
    • Management
    • Board of directors
  • PATIENT CARE
    • IOR
    • IBCC
    • IOB
  • PANGAEA LAB
    • Our Services
      • Molecular diagnostics
      • DX Platforms validation
      • Pre-clinical services
    • R + D
    • Accreditations
  • Publications & newsroom
  • Investors
    • Investor information
    • Corporate governance
    • Financial information
    • Events & Corporate Presentations
    • Inside & other relevant information
  • Contact

Pangaea Lab researchers innovate in liquid biopsy by using pleural fluids for molecular study and at the same time generating cell cultures to analyze the response of gastric and pancreatic cancer to drugs

The study that demonstrates this has been presented at the AACR congress and is the result of the shared leadership of the scientists of Pangaea Lab, one of the centers with the greatest expertise and experience in Spain in liquid biopsy, and IOR, leader in precision oncology.

  • LEGAL ADVICE
  • BYLAWS
  • CONTACT US
  • FOLLOW US
  • MOST READ
  • Whistleblowing Channel

PANGAEA ONCOLOGY. ALL RIGHTS RESERVED, 2025.

DESIGNED & PRODUCED BY SOTO BUSINESS PARTNERS